Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Johanna Elin Gehin; Rolf Anton Klaasen; Eirik Klami Kristianslund; Ingrid Jyssum; Joseph Sexton; David John Warren; Daniel Aletaha; Espen Andre Haavardsholm; Silje Watterdal Syversen; Guro Løvik Goll; Nils Bolstad

Journal title: RMD Open

Journal publisher: BMJ Publishing Group

Published year: 2024

DOI identifier: 10.1136/RMDOPEN-2024-004888

ISSN: 2056-5933